First case of Hb Fontainebleau with sickle haemoglobin and other non-deletional α gene variants identified in neonates during newborn screening for sickle cell disorders

Journal of Clinical Pathology

Volumn 65, Issue 7, 2012, Pages 654-659

  Upadhye, Dipti S ^a   Jain, Dipty ^b   Nair, Sona B ^a   Nadkarni, Anita H ^a   Ghosh, Kanjaksha ^a   Colah, Roshan B ^a  

^a INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

^b GOVERNMENT MEDICAL COLLEGE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; HAPTOGLOBIN O; HEMOGLOBIN; HEMOGLOBIN FONTAINEBLEAU; HEMOGLOBIN KOYA DORA; HEMOGLOBIN S; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CELL COUNT; DNA SEQUENCE; ELECTROPHORESIS; ENCEPHALOCELE; FEMALE; GENE IDENTIFICATION; GENETIC VARIABILITY; GENOTYPE; HEMOGLOBIN BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA;

ALPHA-GLOBINS; ANEMIA, SICKLE CELL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ELECTROPHORESIS, CELLULOSE ACETATE; FEMALE; GENETIC VARIATION; GENOTYPE; HEMOGLOBIN, SICKLE; HEMOGLOBINS, ABNORMAL; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; RETROSPECTIVE STUDIES;

EID: 84863580493     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jclinpath-2011-200642     Document Type: Article

References (27)

1. Sukumaran PK. Abnormal hemoglobins in India. In: Sen NN, Basu AK, eds. Trends in Haematology. J.B. Chaterjea Memorial, India: The Calcutta School of Tropical Medicine, 1975:225-61.
2. King L, Fraser R, Forbes M, et al. Newborn sickle cell disease screening: the Jamaican experience (1995-2006). J Med Screen 2007;14:117-21.
3. Bain BJ. Neonatal/newborn haemoglobinopathy screening in Europe and Africa. J Clin Pathol 2009;62:53-6.
4. Michlitsch J, Azimi M, Hoppe C, et al. Newborn screening for hemoglobinopathies in California. Pediatr Blood Cancer 2009;52:486-90.
5. Lees C, Davies SC, Dezateux C. Neonatal screening for sickle cell disease (Cochrane Review). The Cochrane Library. Issue 1. John Wiley & Sons, Ltd, 2000. http://www.thecochranelibrary.com
6. Mohanty D, Mukherjee MB. Sickle cell disease in India. Curr Opin Hematol 2002;9:117-22. (Pubitemid 34171487)
7. Bain BJ, Lewis SM, Bates I. Basic hematological techniques. In: Lewis SM, Bain BJ, Bates I, eds. Dacie and Lewis Practical Hematology. 10th edn. Philadelphia, PA: Churchill Livingstone, 2006:p25.
8. Tan A, Quah T, Low P, et al. A rapid and reliable 7 deletion multiplex polymerase chain reaction assay for α thalassemia. Blood 2001;98:250.
9. Old JM. DNA based diagnosis of the hemoglobin disorders. In: Steinberg MH, Forget BG, Higgs DR, et al, eds. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management. Cambridge: Cambridge University Press, 2001:946-51.
10. Hardison RC, Chui DH, Giardine B, et al. HbVar: a relational database of hemoglobin variants and thalassaemia mutations at the globin gene server. Hum Mutat 2002;19:225-33. (Pubitemid 34195183)
11. Nair S, Nadkarni A, Warang P, et al. Five α globin chain variants identified during screening for hemoglobinopathies. Eur J Clin Invest 2010;40:226-32.
12. Nakatsuji T, Carver J, Wilson JB, et al. Alpha chain and gamma chain abnormal hemoglobins in newborn babies: structural and genetic aspects. Am J Hematol 1983;14:121-32. (Pubitemid 13121275)
13. Wajcman H, Blouquit Y, Gombaud-Saintonge G, et al. Hb Fontainebleau [alpha 21(B2)Aladpro], a new silent mutant hemoglobin. Hemoglobin 1989;13:412-18.
14. Brennan SO, Chan T, Ryken S, et al. A second case of Hb Fontainebleau [a-21 (B2) Ala→Pro] in an individual with microcytosis. Hemoglobin 2009;33:258-61.
15. Kyrri AR, Felekis X, Kalogerou E, et al. Hemoglobin variants in Cyprus. Hemoglobin 2009;33:81-94.
16. Kendall AG, Barr RD, Lang A, et al. Haemoglobin J Nyanza: a21 (B2) Ala→Asp. Biochim Biophys Acta 1973;310:357-9.
17. Harteveld LC, van Helden WCH, Boxma GL, et al. Hb Zoetermeer: a new mutation on the α2 gene inducing an Ala→Ser substitution at codon 21 is possibly associated with a mild thalassemic phenotype. Hemoglobin 1997;31:325-32.
18. Molchanova TP, Pobedimskaya DD, Huisman TH. The differences in quantities of alpha2- and alpha1- globin gene variants in heterozygotes. Br J Haematol 1994;88:300-6.
19. Saechan V, Nopparatana C, Nopparatana C, et al. Molecular basis and hematological features of hemoglobin variants in Southern Thailand. Int J Hematol 2010;92:445-50.
20. Chopra A, Fisher C, Khunger JM, et al. Hemoglobin O Indonesia in India: a rare observation. Ann Hematol 2011;90:353-4.
21. Bernini LF, De Jong WW, Khan MP. Varanti emoglobiniche nella populazione tribal dell' Andhra P. Molteplicita del locus a Hb nell'como. Atti Assoc Genet Ital 1970;15:191-4.
22. De Jong WW, Khan PM, Bernini LF. Hemoglobin Koya Dora: high frequency of a chain termination mutant. Am J Hum Genet 1975;27:81-90.
23. Brennan SO, Ryken S, Chan T. Hb Koya Dora [α142, Term→Ser (TAA> TCA in a2)]: A rare mutation of the α2 gene stop codon associated with a-thalassemia. Hemoglobin 2010;34:402-5.
24. Milner PF, Clegg JB, Weatherall DJ. Hemoglobin- H disease due to a unique hemoglobin variant with an elongated α chain. Lancet 1971;1:729-32.
25. Clegg JB, Weatherall DJ, Milner PF. Hemoglobin Constant Springda chain termination mutant? Nature 1971;234:337-40.
26. Efremov GD, Wrightstone RN, Huisman TH, et al. An unusual hemoglobin anomaly and its relation to α-thalassemia and hemoglobin- H disease. J Clin Invest 1971;50:1628-36.
27. Viprakasit V, Tanphaichitr VS, Pung-Amritt P, et al. Clinical phenotypes and molecular characterization of HbH-Pakse disease. Hematologica 2002;87:117-25. (Pubitemid 34160616)